RecruitingNCT06981156
Evaluation of the Neurologic Assessment in Pediatric Neuro-Oncology (pNANO)
Sponsor
University of Wisconsin, Madison
Enrollment
75 participants
Start Date
May 13, 2025
Study Type
OBSERVATIONAL
Conditions
Summary
This study aims to investigate a neurologic exam scale to provide an objective and more standard way to assess tumor response in pediatric patients with brain and spinal cord tumors.
Eligibility
Min Age: 1 YearMax Age: 17 Years
Inclusion Criteria4
- greater than or equal to 1 year old
- must be seen in the pediatric clinic
- Radiographic or histologic confirmation of a brain or spine tumor at the time of initial diagnosis
- Patient or parent/guardian must be able to understand the consent and be willing to sign a written informed consent document according to institutional guidelines.
Exclusion Criteria1
- none specified
Interventions
DIAGNOSTIC_TESTpNANO Assessment
pNANO assesses patient gait, strength, cerebellar function, visual fields, visual acuity, facial strength, level of consciousness, extraocular movement, dysarthria, and dysphagia The patient will be assessed by 2-3 different clinicians during each of 2 visits.
Locations(1)
View Full Details on ClinicalTrials.gov
For the most up-to-date information, visit the official listing.
NCT06981156
Related Trials
Intra-Tumoral Injections of Natural Killer Cells for Recurrent Malignant Pediatric Brain Tumors
NCT058878828 locations
High-Intensity Interval Exercise in Young Adult Survivors of Pediatric Brain Tumors: A Pilot Feasibility Study
NCT057408391 location
HSV G207 in Children With Recurrent or Refractory Cerebellar Brain Tumors
NCT039113883 locations
GPC2-CAR T Cell Therapy for Relapsed or Refractory Medulloblastoma in Children and Young Adults
NCT070870021 location
Survivors Journey+
NCT073213532 locations